Sanders Morris Harris

Sanders Morris Harris is a Houston-based financial services firm that provides investment banking, wealth management, and institutional services to a diverse range of clients. While not a biotechnology company itself, it is highly relevant to the life sciences sector through its dedicated investment banking division, which specializes in capital raising and strategic advisory for mid-market healthcare and biotech firms. The firm has a significant track record of lead-managing initial public offerings (IPOs), private placements, and mergers and acquisitions within the life sciences industry. By bridging the gap between innovative healthcare entities and institutional capital, Sanders Morris Harris serves as a key financial architect for emerging growth companies in the medical field. Following its 2023 acquisition by Tavis Capital, the firm continues to provide specialized financial solutions for the healthcare innovation ecosystem.